Key result
Incubation with hydrocortisone sodium succinate prevented platelet aggregation in canine platelet rich plasma stimulated by ADP, thrombin, collagen, and endotoxin, and induced deaggregation.
Why the study?
Does hydrocortisone sodium succinate inhibit or reverse platelet aggregation in canine platelet rich plasma?
Does hydrocortisone sodium succinate inhibit or reverse platelet aggregation in canine platelet rich plasma?
Hydrocortisone sodium succinate inhibits and reverses in vitro platelet aggregation, providing a potential mechanism for its beneficial effects in shock.
Answers are grounded in this paper and cite their sources.
May explain hydrocortisone effects in shock; leaves open translation from canine in vitro data.
Citrated canine platelet rich plasma stimulated with ADP, thrombin, collagen and E. coli endotoxin demonstrated platelet aggregation when measured with Payton aggregometer. Following incubation with hydrocortisone sodium succinate (Solu-Cortef) the same platelet rich plasma did not undergo platelet aggregation when stimulated by these agents. Solu-Cortef added to platelet rich plasma during ATP, thrombin, collagen and endotoxin stimulated platelet aggregation resulted in a reversal of the optical density suggesting deaggregation. These in vitro observations support the beneficial effects observed when steroids are administered in vivo to experimental or clinical shock.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (1975) studied Endotoxin induced platelet aggregation. Hydrocortisone sodium succinate (Solu-Cortef) was evaluated on Platelet aggregation and deaggregation. Incubation with hydrocortisone sodium succinate prevented platelet aggregation in canine platelet rich plasma stimulated by ADP, thrombin, collagen, and endotoxin, and induced deaggregation.
Synapse has enriched 10 related papers. Consider them for comparative context: